SG11201505089YA - Method of making a mycoplasma vaccine - Google Patents

Method of making a mycoplasma vaccine

Info

Publication number
SG11201505089YA
SG11201505089YA SG11201505089YA SG11201505089YA SG11201505089YA SG 11201505089Y A SG11201505089Y A SG 11201505089YA SG 11201505089Y A SG11201505089Y A SG 11201505089YA SG 11201505089Y A SG11201505089Y A SG 11201505089YA SG 11201505089Y A SG11201505089Y A SG 11201505089YA
Authority
SG
Singapore
Prior art keywords
making
mycoplasma vaccine
mycoplasma
vaccine
Prior art date
Application number
SG11201505089YA
Other languages
English (en)
Inventor
Dianna M Murphy Jordan
Brian Thomas Martinson
Christine Margaret Muehlenthaler
Axel Neubauer
Arun V Iyer
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49917778&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201505089Y(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of SG11201505089YA publication Critical patent/SG11201505089YA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0241Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36Adaptation or attenuation of cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0684Cells of the urinary tract or kidneys
    • C12N5/0686Kidney cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00Coculture with; Conditioned medium produced by
    • C12N2502/70Non-animal cells
SG11201505089YA 2012-12-28 2013-12-20 Method of making a mycoplasma vaccine SG11201505089YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261746997P 2012-12-28 2012-12-28
PCT/US2013/076807 WO2014105672A1 (en) 2012-12-28 2013-12-20 Method of making a mycoplasma vaccine

Publications (1)

Publication Number Publication Date
SG11201505089YA true SG11201505089YA (en) 2015-07-30

Family

ID=49917778

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201505089YA SG11201505089YA (en) 2012-12-28 2013-12-20 Method of making a mycoplasma vaccine
SG10201708028VA SG10201708028VA (en) 2012-12-28 2013-12-20 Method of making a mycoplasma vaccine

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10201708028VA SG10201708028VA (en) 2012-12-28 2013-12-20 Method of making a mycoplasma vaccine

Country Status (23)

Country Link
US (2) US9273281B2 (ja)
EP (1) EP2938747B1 (ja)
JP (2) JP6122146B2 (ja)
KR (1) KR102153275B1 (ja)
CN (2) CN104968365B (ja)
AR (1) AR094648A1 (ja)
AU (1) AU2013370983B2 (ja)
BR (1) BR112015012711B1 (ja)
CA (1) CA2896298C (ja)
CL (1) CL2015001562A1 (ja)
DK (1) DK2938747T3 (ja)
EA (1) EA032772B1 (ja)
ES (1) ES2738100T3 (ja)
HU (1) HUE045015T2 (ja)
MX (1) MX361273B (ja)
MY (1) MY173223A (ja)
PH (1) PH12015501333A1 (ja)
PL (1) PL2938747T3 (ja)
PT (1) PT2938747T (ja)
SG (2) SG11201505089YA (ja)
TW (2) TWI618542B (ja)
UA (1) UA121193C2 (ja)
WO (1) WO2014105672A1 (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8546149B2 (en) 2010-08-27 2013-10-01 Intervet Inc. Potency test for vaccine formulations
EP2938356B1 (en) * 2012-12-28 2020-05-13 Boehringer Ingelheim Vetmedica GmbH Immunogenic composition comprising mycoplasma antigens
CN104968365B (zh) * 2012-12-28 2018-04-03 勃林格殷格翰动物保健有限公司 支原体疫苗的制备方法
CN105441368B (zh) * 2016-01-19 2019-01-01 福清市默克兽医院 一株牛支原体及其应用
WO2017132578A1 (en) * 2016-01-29 2017-08-03 Advanced Animal Diagnostics, Inc. Methods and compositions for detecting mycoplasma exposure
EP3778626A1 (en) * 2016-08-09 2021-02-17 Agricultural Technology Research Institute Composition for preventing and treating mycoplasma hyorhinis infection, and method for producing said composition
EP3576799A4 (en) * 2017-02-03 2020-12-30 The Administrators of The Tulane Educational Fund OPHTHALMIC COMPOSITIONS FOR THERAPY AND PROPHYLAXIS
CN110650989B (zh) 2017-05-24 2023-03-31 三菱化学株式会社 成型材料、及纤维增强复合材料
MX2021015170A (es) 2019-06-10 2022-03-22 Elanco Us Inc Formulaciones de medios de micoplasma.
CN113201050B (zh) * 2020-08-06 2022-07-22 青岛诺安百特生物技术有限公司 一种金黄色葡萄球菌噬菌体穿孔素及其制备方法和应用

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909462A (en) 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
GB1074920A (en) * 1965-04-21 1967-07-05 Pfizer & Co C Growth medium for mycoplasma pneumoniae and vaccine production
ES343655A1 (es) * 1966-07-11 1968-09-01 Research Corp Metodo para la preparacion de un inoculo para aves de co- rral.
JPS5540568B2 (ja) 1972-10-05 1980-10-18
US5338543A (en) 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
US5885823A (en) 1995-06-05 1999-03-23 Nobl Laboratories, Inc. Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
KR100797547B1 (ko) * 2000-03-03 2008-01-24 자이단호진 가가쿠오요비겟세이료호겐쿠쇼 무혈청 배양 및 부유 배양에서 사용할 수 있는 세포 및상기 세포를 사용하여 백신용 바이러스를 제조하는 방법
JP3402304B2 (ja) * 2000-03-30 2003-05-06 株式会社微生物化学研究所 猫クラミジアワクチンの製造方法
US7018638B2 (en) 2000-12-19 2006-03-28 Wyeth Mycoplasma hyopneumoniae bacterin vaccine
MY129765A (en) 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
CA2452666A1 (en) 2001-07-02 2003-01-16 Pfizer Products Inc. Mycoplasma hyopneumoniae vaccine and methods for reducing mycoplasma bovis pneumonia in cattle
US20030147914A1 (en) 2001-07-02 2003-08-07 Pfizer Inc. Mycoplasma bovis vaccine and methods of reducing pneumonia in animals
ATE412426T2 (de) 2001-07-02 2008-11-15 Pfizer Prod Inc Vakzination in einer dosis mit i mycoplasma hyopneumoniae /i
PL368826A1 (en) 2001-08-28 2005-04-04 Pfizer Products Inc. Mycoplasma bovis challenge model, methods for administering m. bovis and methods for inducing pneumonic lung lesions
TWI238721B (en) * 2003-06-20 2005-09-01 Animal Technology Inst Taiwan Swine enzootic vaccine, its producing method and usage
WO2006084364A1 (en) 2005-02-09 2006-08-17 Magna International Inc. Method of manufacturing a semi-structural panel
WO2006095431A1 (ja) * 2005-03-10 2006-09-14 Kyoritsu Seiyaku Corporation 動物由来の成分なしで培養可能である細胞株及びその作出方法、これを用いたウイルスの生産方法、及びワクチンの生産方法
WO2007042827A2 (en) * 2005-10-14 2007-04-19 Ivan Petyaev Treatment and diagnosis of obligate intracellular pathogens
EP2615167A1 (en) 2006-09-15 2013-07-17 MedImmune, LLC Method for eliminating DNA contaminants from viral preparations
US20090068231A1 (en) 2007-09-11 2009-03-12 Wyeth Live attenuated mycoplasma strains
AR069087A1 (es) 2007-10-29 2009-12-30 Boehringer Ingelheim Vetmed Cepa bacteriana de m. bovis atenuada avirulenta obtenida por pases, vacuna de micoplasma boris y metodos de uso de la misma
MX2010005014A (es) 2007-11-06 2010-06-30 Wyeth Llc Vacuna viva avirulenta de mycoplasma hyopneumoniae con adyuvante.
US20090317423A1 (en) 2008-01-23 2009-12-24 Boehringer Ingelheim Vetmedica, Inc. Pcv2 mycoplasma hyopneumoniae immunogenic compositions and methods of producing such compositions
US8444989B1 (en) 2008-04-18 2013-05-21 Boehringer Ingelheim Vetmedica Gmbh One dose vaccination against mycoplasma infections of pigs
WO2009142086A1 (ja) 2008-05-23 2009-11-26 学校法人久留米大学 マイコプラズマ感染症用ワクチン組成物
DK2310046T3 (da) 2008-06-27 2016-04-25 Zoetis Services Llc Hidtil ukendte adjuvanssammensætninger
WO2010051210A1 (en) 2008-10-31 2010-05-06 Boehringer Ingelheim Vetmedica, Inc. Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition
MX2011012362A (es) 2009-05-19 2012-04-19 Bioproperties Pty Ltd Cepa de vacuna de mycoplasma hyopneumoniae sensible a la temperatura y usoz de la misma.
US20110150770A1 (en) 2009-12-18 2011-06-23 Boehringer Ingelheim Vetmedica, Inc. Multivalent vaccine against porcine teschovirus and other disease causing organisms in swine
US8112663B2 (en) 2010-03-26 2012-02-07 Lsi Corporation Method to establish redundancy and fault tolerance better than RAID level 6 without using parity
CN102258776B (zh) 2011-07-07 2013-07-10 普莱柯生物工程股份有限公司 猪肺炎支原体、猪鼻支原体二联灭活疫苗及其制备方法
UA114503C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
EP2938356B1 (en) 2012-12-28 2020-05-13 Boehringer Ingelheim Vetmedica GmbH Immunogenic composition comprising mycoplasma antigens
CN104968365B (zh) 2012-12-28 2018-04-03 勃林格殷格翰动物保健有限公司 支原体疫苗的制备方法

Also Published As

Publication number Publication date
CA2896298A1 (en) 2014-07-03
MX361273B (es) 2018-12-03
KR102153275B1 (ko) 2020-09-09
ES2738100T3 (es) 2020-01-20
EP2938747B1 (en) 2019-05-01
BR112015012711A2 (pt) 2017-07-11
TWI660736B (zh) 2019-06-01
US10512680B2 (en) 2019-12-24
PL2938747T3 (pl) 2019-11-29
JP6449364B2 (ja) 2019-01-09
MX2015007730A (es) 2015-09-07
PT2938747T (pt) 2019-08-01
US20160136254A1 (en) 2016-05-19
BR112015012711B1 (pt) 2022-08-16
EA201500701A1 (ru) 2015-12-30
US9273281B2 (en) 2016-03-01
US20140186394A1 (en) 2014-07-03
PH12015501333A1 (en) 2015-09-02
HUE045015T2 (hu) 2019-11-28
AU2013370983B2 (en) 2019-09-26
UA121193C2 (uk) 2020-04-27
CL2015001562A1 (es) 2016-06-24
CN104968365A (zh) 2015-10-07
CA2896298C (en) 2024-01-16
CN104968365B (zh) 2018-04-03
DK2938747T3 (da) 2019-08-05
KR20150100920A (ko) 2015-09-02
WO2014105672A1 (en) 2014-07-03
EP2938747A1 (en) 2015-11-04
CN108379571A (zh) 2018-08-10
TW201832777A (zh) 2018-09-16
TWI618542B (zh) 2018-03-21
TW201438732A (zh) 2014-10-16
JP6122146B2 (ja) 2017-04-26
AU2013370983A1 (en) 2015-05-21
JP2017145253A (ja) 2017-08-24
EA032772B1 (ru) 2019-07-31
JP2016508983A (ja) 2016-03-24
MY173223A (en) 2020-01-07
SG10201708028VA (en) 2017-10-30
AR094648A1 (es) 2015-08-19

Similar Documents

Publication Publication Date Title
HK1207967A1 (en) Vaccine
SG11201505089YA (en) Method of making a mycoplasma vaccine
GB2501243B (en) Method of making a medical balloon
EP2913831A4 (en) PROCESS FOR PRODUCING RARE EARTH MAGNET
EP2939754A4 (en) DRAWING FORM PROCEDURE
EP2876161A4 (en) VACCINE
GB201223386D0 (en) Vaccine
IL234024A0 (en) A method for making a multi-layered item
GB2517862B (en) Method of marking a line
PL2931937T3 (pl) Sposób wytwarzania układów nanocząstek metali
SG11201504454RA (en) A method of vitrification
PL2809816T3 (pl) Sposób ekspresji
EP2824130A4 (en) PROCESS FOR PRODUCING POLYDIALKYLSILANE
GB201220155D0 (en) Method of manufacture
LU92341B1 (en) Method of producing a shaped component
SG2013017017A (en) A method of separation
HRP20181348T1 (hr) Postupak izrade panela
SG2013085071A (en) Method of producing methionine
PL2662656T3 (pl) Sposób wykonania grzejnika
EP2832696A4 (en) MAYENITHERSTELLUNGSVERFAHREN
GB201215942D0 (en) Method of treatent
HK1208864A1 (en) A preparation method of ecteinascidin-743 intermediate -743
GB201215939D0 (en) Method of preparing monomers
EP2812301A4 (en) PROCESS FOR PREPARING ALCOHOLS
GB201210540D0 (en) Method of making a product